Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05658926 · ClinicalTrials.gov registry record · NA

A Brief Intervention for Patients on Opioids for Acute Pain

A NA study of Acute Pain, sponsored by Henry Ford Health System.

Completed
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT05658926: Completed NA study of Acute Pain, sponsored by Henry Ford Health System.

NCT05658926 is a NA study of Acute Pain that has completed, run by Henry Ford Health System. The registered enrollment target is 60 participants, below the 267-participant average among 50 other Acute Pain trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05658926, a NA study of Acute Pain, has completed, sponsored by Henry Ford Health System.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

This study aims to evaluate benefits of a brief intervention for patients who are prescribed opioids for acute pain.

Primary Outcome

Pain severity rated on a 0-10 scale

Conditions Studied

Interventions

  • OTHER Education
  • BEHAVIORAL Mindfulness

Study Locations (1)

Michigan

  • Henry Ford Health System - Detroit

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2017-09-01
Est. Completion 2018-04-30
Phase NA
Henry Ford Health System

234 total trials

What the finished NCT05658926 record still lists

NCT05658926 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 267-participant average among 50 other Acute Pain trials with a reported enrollment target (78% lower).

The record links to 1 condition, with Acute Pain appearing as the primary indexed condition, and to 2 interventions - of which Education is the first listed.

NCT05658926 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT05658926 about?

NCT05658926 is a clinical study titled "A Brief Intervention for Patients on Opioids for Acute Pain". This study aims to evaluate benefits of a brief intervention for patients who are prescribed opioids for acute pain.

What is the current status of trial NCT05658926?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2017-09-01. Estimated completion is 2018-04-30.

What conditions does trial NCT05658926 study?

This clinical trial studies the following conditions: Acute Pain.

What interventions are being tested in trial NCT05658926?

The interventions under investigation include: Education (OTHER), Mindfulness (BEHAVIORAL).

Who is sponsoring clinical trial NCT05658926?

This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05658926 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Acute Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05658926's enrollment target sits among peer trials

60 36th of 50 higher than 14 of 50 other Acute Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Acute Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05658926, the US trial registry maintained by the National Library of Medicine. NCT05658926 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.